Intravenous Iron Replacement Improves Quality of Life in Hypoferritinemic Inflammatory Bowel Disease Patients with and without Anemia

Digestive Diseases

Volumn 35, Issue 5, 2017, Pages 444-448

  Eliadou, Elena ^a   Kini, Gregory ^a   Huang, Judy ^a   Champion, Amy ^a   Inns, Stephen James ^a,b  

^a Hutt Valley District Health Board   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Anemia; Crohn disease; Hypoferritinemia; Inflammatory bowel disease; Iron; Ulcerative colitis

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; IRON; IRON POLYMALTOSE; TRANSFERRIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CROHN DISEASE; DISEASE ACTIVITY SCORE; HUMAN; HYPOFERRITINEMIA; INFLAMMATORY BOWEL DISEASE; IRON DEFICIENCY ANEMIA; IRON REPLACEMENT; IRON THERAPY; MENTAL COMPONENT SCORE; OPEN STUDY; OUTCOME ASSESSMENT; PHYSICAL COMPONENT SCORE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE ASSESSMENT; QUESTIONNAIRE; SHORT FORM 36; STUDY DESIGN; SUBSTITUTION THERAPY; ULCERATIVE COLITIS; ANEMIA; BLOOD; CLINICAL TRIAL; COMPLICATION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; QUALITY OF LIFE;

ADMINISTRATION, INTRAVENOUS; ADULT; AGED; ANEMIA; FEMALE; FERRITINS; HUMANS; INFLAMMATORY BOWEL DISEASES; IRON; MALE; MIDDLE AGED; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES;

EID: 85016637263     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000468145     Document Type: Article

References (23)

1. Dignass AU, Gasche C, Bettenworth D, Birgegard G, Danese S, Gisbert JP, Gomollon F, Iqbal T, Katsanos K, Koutroubakis I, Magro F, Savoye G, Stein J, Vavricka S; European Crohn's and Colitis Organisation [ECCO]: European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis 2015; 9: 211-222.
2. Wells CW, Lewis S, Barton JR, Corbett S: Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006; 12: 123-130.
3. Cucino C, Sonnenberg A: Cause of death in patients with inflammatory bowel disease. Inflamm Bowel Dis 2001; 7: 250-255.
4. Wilson A, Reyes E, Ofman J: Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med 2004; 116(suppl 7A): 44S-49S.
5. Kulnigg S, Gasche C: Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006; 24: 1507-1523.
6. Lomer MC, Kodjabashia K, Hutchinson C, Greenfield SM, Thompson RP, Powell JJ: Intake of dietary iron is low in patients with Crohn's disease: a case-control study. Br J Nutr 2004; 91: 141-148.
7. de Vizia B, Poggi V, Conenna R, Fiorillo A, Scippa L: Iron absorption and iron deficiency in infants and children with gastrointestinal diseases. J Pediatr Gastroenterol Nutr 1992; 14: 21-26.
8. Semrin G, Fishman DS, Bousvaros A, Zholudev A, Saunders AC, Correia CE, Nemeth E, Grand RJ, Weinstein DA: Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis 2006; 12: 1101-1106.
9. Gasche C, Berstad A, Befrits R, Beglinger C, Dignass A, Erichsen K, Gomollon F, Hjortswang H, Koutroubakis I, Kulnigg S, Oldenburg B, Rampton D, Schroeder O, Stein J, Travis S, Van Assche G: Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007; 13: 1545-1553.
10. de Silva AD, Tsironi E, Feakins RM, Rampton DS: Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther 2005; 22: 1097-1105.
11. Uritski R, Barshack I, Bilkis I, Ghebremeskel K, Reifen R: Dietary iron affects inflammatory status in a rat model of colitis. J Nutr 2004; 134: 2251-2255.
12. Carrier J, Aghdassi E, Platt I, Cullen J, Allard JP: Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther 2001; 15: 1989-1999.
13. Werner T, Wagner SJ, Martinez I, Walter J, Chang JS, Clavel T, Kisling S, Schuemann K, Haller D: Depletion of luminal iron alters the gut microbiota and prevents Crohn's diseaselike ileitis. Gut 2011; 60: 325-333.
14. Reinisch W, Staun M, Bhandari S, Munoz M: State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. J Crohns Colitis 2013; 7: 429-440.
15. Cekic C, Ipek S, Aslan F, Akpinar Z, Arabul M, Topal F, Saritas Yuksel E, Alper E, Unsal B: The effect of intravenous iron treatment on quality of life in inflammatory bowel disease patients with nonanemic iron deficiency. Gastroenterol Res Pract 2015; 2015: 582163.
16. Sobrado CW, Cancado RD, Sobrado LF, Frugis MO, Sobrado MF: Treatment of anemia and improvement of quality of life among patients with Crohn's disease: experience using ferric carboxymaltose. Arq Gastroenterol 2015; 52: 255-259.
17. Herrera-deGuise C, Casellas F, Robles V, Navarro E, Borruel N: Iron deficiency in the absence of anemia impairs the perception of health-related quality of life of patients with inflammatory bowel disease. Inflamm Bowel Dis 2016; 22: 1450-1455.
18. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, Jewell DP, Karban A, Loftus EV Jr, Pena AS, Riddell RH, Sachar DB, Schreiber S, Steinhart AH, Targan SR, Vermeire S, Warren BF: Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19(suppl A):5A-36A.
19. Harvey RF, Bradshaw JM: A simple index of Crohn's-disease activity. Lancet 1980; 1: 514.
20. Walmsley RS, Ayres RC, Pounder RE, Allan RN: A simple clinical colitis activity index. Gut 1998; 43: 29-32.
21. Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, Tompkins C: A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989; 96: 804-810.
22. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
23. Schroder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H, Reinshagen M, Schreiber S, Junge U, Schrott M, Stein J: Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease-a randomized, controlled, open-label, multicenter study. Am J Gastroenterol 2005; 100: 2503-2509.